Welcome!
CGS-CIMB Research
Broker's Calls
Singtel expected to meet FY2022 estimates: CGS-CIMB
Singtel is expected to meet its FY2022 estimates, largely due to better contribution by its associates.
May 25, 2022
Broker's Calls
Netlink’s strong operating cash flow generation can continue to support stable DPU growth: CGS-CIMB
CGS-CIMB and DBS analysts have maintained their “add” and “buy” calls for NetLink NBN Trust with unchanged TPs of $1.10 and $1.05.
May 23, 2022
Broker's Calls
Analysts positive on Hyphens Pharma as 1Q results beat expectations
CGS-CIMB gives a target price of 36 cents, while SAC Capital hands Hyphens a 40 cents target price.
May 20, 2022
Broker's Calls
Analysts mixed on Golden Agri; CGS-CIMB downgrades to 'hold' due to policy concerns
Analysts are mixed on Golden Agri on the ongoing Indonesia palm oil export ban and the possibility of CPO trending lower.
May 18, 2022
Broker's Calls
CGS-CIMB keeps ‘add’ on Q&M Dental as part of managing post-Covid-19 growth expectations
Photo: Albert Chua/The Edge Singapore
May 17, 2022
Broker's Calls
CGS-CIMB ups UMS's revenue forecasts on its strong order book
CGS-CIMB analyst William Tng has kept his target price unchanged at $1.63 on UMS.
May 13, 2022
Broker's Calls
After doubling net profit y-o-y, BRC Asia to recover further: CGS-CIMB
The brokerage has upped its TP to $2.50 from $2.10 before.
May 13, 2022
Broker's Calls
Broker's Digest: CapitaLand Integrated Commercial Trust and Manulife US REIT
Here's what the analysts have to say this week.
May 13, 2022
Broker's Calls
Jiutian to benefit from elevated prices, set to last till 2023: analysts
“Even if the Chinese government approves new supply, it would still require a minimum of nine to 12 months for trials.”
May 12, 2022
Broker's Calls
Analysts positive on Elite Commercial REIT; sees REIT as a 'good inflation hedge'
During the quarter, the REIT saw revenue increase by 39.4% y-o-y to £9.2 million ($15.8 million)
May 11, 2022